The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dulcolax 5mg Gastro-resistant Tablets

5 milligram(s) Gastro-resistant tablet

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/184/003

Main Information

Trade NameDulcolax 5mg Gastro-resistant Tablets
Active SubstancesBisacodyl
Strength5 milligram(s)
Dosage FormGastro-resistant tablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/184/003

Group Information

ATC CodeA06AB Contact laxatives
A06AB02 bisacodyl

Status

Authorised/WithdrawnAuthorised
Licence Issued05/06/1986
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceTo the public for the treatment of constipation for adults only. To the professions for other age groups and indications. 1. Not to be given to children except on medical advice. 2. If laxatives are needed every day or there is persistent abdominal pain, consult your doctor.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back